| Hans-Günter Meyer-Thompson | Buprenorphin
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
Lee, Joshua D et al.
The Lancet , Volume 0 , Issue 0 , Published: 14 November 2017, doi.org/10.1016/S0140-6736(17)32812-X
Abstract
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32812-X/fulltext